129 related articles for article (PubMed ID: 11899646)
21. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
[TBL] [Abstract][Full Text] [Related]
22. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
[TBL] [Abstract][Full Text] [Related]
23. Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.
Fehm T; Becker S; Becker-Pergola G; Sotlar K; Gebauer G; Dürr-Störzer S; Neubauer H; Wallwiener D; Solomayer EF
Breast Cancer Res; 2006; 8(5):R60. PubMed ID: 17062129
[TBL] [Abstract][Full Text] [Related]
24. [Micrometastases in pediatric oncology].
Bernard F; Aerts I; Margueritte G; Astruc J
Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
[TBL] [Abstract][Full Text] [Related]
26. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
28. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
Effenberger KE; Borgen E; Eulenburg CZ; Bartkowiak K; Grosser A; Synnestvedt M; Kaaresen R; Brandt B; Nesland JM; Pantel K; Naume B
Breast Cancer Res Treat; 2011 Feb; 125(3):729-38. PubMed ID: 20449649
[TBL] [Abstract][Full Text] [Related]
29. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K
Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327
[TBL] [Abstract][Full Text] [Related]
30. [Bone marrow isolated micrometastases of non-small cell lung cancer].
Dancewicz M; Kowalewski J; Sir J; Pepliński J; Jezierska A
Pol Merkur Lekarski; 2006 Mar; 20(117):315-7. PubMed ID: 16780264
[TBL] [Abstract][Full Text] [Related]
31. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
32. [The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer].
Janni W; Strobl B; Rack B; Rjosk D; Schindlbeck C; Hantschmann P; Kentenich C; Sigg W; Zerzer M; Sommer H
Dtsch Med Wochenschr; 2002 Jan; 127(3):71-7. PubMed ID: 11797143
[TBL] [Abstract][Full Text] [Related]
33. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
[TBL] [Abstract][Full Text] [Related]
34. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
35. Occult metastases in patients with breast cancer.
Hawes D; Neville AM; Cote RJ
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):60S-63S. PubMed ID: 11599903
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of disseminated tumor cells in breast cancer.
Slade MJ; Coombes RC
Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
[TBL] [Abstract][Full Text] [Related]
37. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
Janku F; Kleibl Z; Novotny J; Tesarova P; Petruzelka L; Matous B
Neoplasma; 2004; 51(3):204-8. PubMed ID: 15254674
[TBL] [Abstract][Full Text] [Related]
38. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.
Galán M; Viñolas N; Colomer D; Soler G; Muñoz M; Longarón R; Ventura PJ; Gascón P; Estapé J
Anticancer Res; 2002; 22(5):2877-84. PubMed ID: 12530011
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients.
Braun S; Pantel K
Oncologist; 2001; 6(2):125-32. PubMed ID: 11306724
[TBL] [Abstract][Full Text] [Related]
40. Detection of micrometastatic disease in bone marrow: is it ready for prime time?
Janni W; Rack B; Lindemann K; Harbeck N
Oncologist; 2005 Aug; 10(7):480-92. PubMed ID: 16079315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]